0002036372-26-000003.txt : 20260925 0002036372-26-000003.hdr.sgml : 20260925 20260925103736 ACCESSION NUMBER: 0002036372-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20260925 DATE AS OF CHANGE: 20260925 EFFECTIVENESS DATE: 20260925 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OptoVista Holdings, LLC CENTRAL INDEX KEY: 0002036372 ORGANIZATION NAME: EIN: 994025152 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-598840 FILM NUMBER: 261406946 BUSINESS ADDRESS: STREET 1: 1200 G STREET, NW CITY: WASHINGTON STATE: DC ZIP: 20005 BUSINESS PHONE: 703-919-6983 MAIL ADDRESS: STREET 1: 1200 G STREET, NW CITY: WASHINGTON STATE: DC ZIP: 20005 D 1 primary_doc.xml X0708 D LIVE 0002036372 OptoVista Holdings, LLC C/O Tern Therapeutics, 1200 G STREET, NW Suite 800 WASHINGTON DC DISTRICT OF COLUMBIA 20005 703-919-6983 DELAWARE None None Limited Liability Company true 2023 Matthew Michael Rosini C/O Tern Therapeutics, 1200 G Street, NW Suite 800 Washington DC DISTRICT OF COLUMBIA 20005 Executive Officer Alexander Bailey C/O Tern Therapeutics, 1200 G Street, NW Suite 800 Washington DC DISTRICT OF COLUMBIA 20005 Executive Officer Director Christina Ohnsman C/O Tern Therapeutics, 1200 G Street, NW Suite 800 Washington DC DISTRICT OF COLUMBIA 20005 Executive Officer Steven Oliveira C/O Tern Therapeutics, 1200 G Street, NW Suite 800 Washington DC DISTRICT OF COLUMBIA 20005 Director Kerry Propper C/O Tern Therapeutics, 1200 G Street, NW Suite 800 Washington DC DISTRICT OF COLUMBIA 20005 Director Biotechnology Decline to Disclose 06c false 2026-09-11 false true false 0 3727518 3727518 0 false 7 0 0 0 false OptoVista Holdings, LLC Matthew Michael Rosini Matthew Michael Rosini Chief Financial Officer 2026-09-25